Massively Parallel Reporter Assays (MPRAs) quantify the activity of 10-100s of thousands of sequences, however, it is not feasible to test all known variation. Modeling MPRA can increase scale and lead to better understanding of complex traits, somatic and germline diseases, and population genetics.
